Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer

To evaluate the feasibility of amrubicin plus cisplatin (AP) following chemoradiotherapy for limited‐disease small‐cell lung cancer, chemo‐naïve patients aged 20–70 years with a performance status of 0 or 1 and normal organ functions were treated with etoposide 100 mg/m(2) on days 1–3, cisplatin 80...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Sekine, Ikuo, Sumi, Minako, Satouchi, Miyako, Tsujino, Kayoko, Nishio, Makoto, Kozuka, Takuyo, Niho, Seiji, Nihei, Keiji, Yamamoto, Nobuyuki, Harada, Hideyuki, Ishikura, Satoshi, Tamura, Tomohide
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814250/
https://ncbi.nlm.nih.gov/pubmed/26748638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12875
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares